Omnicell (OMCL) Tops Q3 EPS by 5c; Lowers Outlook

Omnicell (NASDAQ: OMCL) reported Q3 EPS of $1.00, $0.05 better than the analyst estimate of $0.95. Revenue for the quarter came in at $348 million versus the consensus estimate of $363.24 million.

GUIDANCE:

Omnicell sees Q4 2022 EPS of $0.05-$0.15, versus the consensus of $1.21. Omnicell sees Q4 2022 revenue of $285-295 million, versus the consensus of $382.33 million.

Omnicell sees FY2022 EPS of $2.73-$2.83, versus the consensus of $3.84. Omnicell sees FY2022 revenue of $1.284-1.294 billion, versus the consensus of $1.4 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight